TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33590715

Group type: EXPERIMENTAL
Intervention: Autologous serum eye drops (SEDs)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Allogeneic serum eye drops (SEDs)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Comparison of autologous and allogeneic SEDs
Number of subjects: 19
Study: 36501047

Group type: EXPERIMENTAL
Intervention: Synbiotic containing a mixture of Lactobacillus and Bifidobacterium and fructooligosaccharide for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Synbiotic
Number of subjects: 40
Study: 34214475

Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study: 32720190

Group type: EXPERIMENTAL
Intervention: Family Bereavement Program (FBP)
Number of subjects: 152
Study: 36068494

Group type: EXPERIMENTAL
Intervention: eptinezumab 100 mg or 300 mg, administered intravenously once every 12 weeks for up to two doses
Number of subjects: 1072

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1072
Study: 33257805

Group type: EXPERIMENTAL
Intervention: Frequent symptoms of dry eye
Number of subjects: 2045

Group type: EXPERIMENTAL
Intervention: Tear-film break-up time ≤ 10 s
Number of subjects: 2045

Group type: EXPERIMENTAL
Intervention: Schirmer test score ≤ 5 mm
Number of subjects: 2045

Group type: EXPERIMENTAL
Intervention: Meibomian gland disease
Number of subjects: 2045

Group type: EXPERIMENTAL
Intervention: Fluorescein staining of the cornea
Number of subjects: 2045
Study: 36360813

Group type: EXPERIMENTAL
Intervention: Multicomponent Empowerment-Based Psychosocial Intervention
Number of subjects: 111

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 111
Study: 34980047

Group type: EXPERIMENTAL
Intervention: Lung recruitment plus INSURE
Number of subjects: 184

Group type: COMPARATOR
Intervention: INSURE only (Control)
Number of subjects: 184
Study: 34269427

Group type: EXPERIMENTAL
Intervention: Rational Emotive Occupational Health Coaching (REOHC) for 12 weeks
Number of subjects: 84
Study: 36469686

Group type: EXPERIMENTAL
Intervention: Group singing (GS) intervention
Number of subjects: 149
Study: 33961539

Group type: EXPERIMENTAL
Intervention: Message recommending vaccination at age 11–12
Number of subjects: 1263

Group type: EXPERIMENTAL
Intervention: Message recommending fewer doses at age 11–12
Number of subjects: 1263

Group type: EXPERIMENTAL
Intervention: Message recommending fewer doses before age 15
Number of subjects: 1263

Group type: COMPARATOR
Intervention: No message
Number of subjects: 1263
Study: 34181180

Group type: EXPERIMENTAL
Intervention: Housing First with Assertive Community Treatment (HF with ACT)
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Housing First with Intensive Care Management (HF with ICM)
Number of subjects: 575

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 575
Study: 35138577

Group type: EXPERIMENTAL
Intervention: Integrative analysis of randomized clinical trial (RCT) and observational study data
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized clinical trial (RCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observational study data
Number of subjects: 0
Study: 33617796

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (25 μg) with Foley catheter
Number of subjects: 215

Group type: COMPARATOR
Intervention: Buccal misoprostol (25 μg) with Foley catheter
Number of subjects: 215
Study: 32616595

Group type: EXPERIMENTAL
Intervention: Stereotactic ablative radiotherapy (SABR)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: SABR
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: SABR and Surgery
Number of subjects: 54
Study: 35548914

Group type: EXPERIMENTAL
Intervention: Immersive virtual reality
Number of subjects: 5

Group type: COMPARATOR
Intervention: Non-immersive and semi-immersive VR
Number of subjects: 5
Study: 36177538

Group type: EXPERIMENTAL
Intervention: App use (intervention group)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study: 33538149

Group type: EXPERIMENTAL
Intervention: UVC-treated platelets
Number of subjects: 171
Study: 32307568

Group type: EXPERIMENTAL
Intervention: Bosutinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imatinib
Number of subjects: 0
Study: 36347833

Group type: EXPERIMENTAL
Intervention: MusicGlove
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control
Number of subjects: 10
Study: 32062791

Group type: EXPERIMENTAL
Intervention: Revusiran 500 mg subcutaneously daily for 5 days followed by weekly doses
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Revusiran
Number of subjects: 206
Study: 35565955

Group type: EXPERIMENTAL
Intervention: 16-week personalized healthy eating, sleep hygiene, and physical activity program
Number of subjects: 125

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 125
Study: 32019354

Group type: EXPERIMENTAL
Intervention: Independently derived recommended strategies for managing bipolar II disorder
Number of subjects: 18
Study: 35059912

Group type: EXPERIMENTAL
Intervention: Conventional aerosol box
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Modified aerosol box
Number of subjects: 16

Group type: COMPARATOR
Intervention: No aerosol box
Number of subjects: 16
Study: 33570548

Group type: EXPERIMENTAL
Intervention: Salvage radiotherapy (sRT) with or without 2 years of bicalutamide
Number of subjects: 352

Group type: COMPARATOR
Intervention: Bicalutamide
Number of subjects: 352
Study: 36343030

Group type: EXPERIMENTAL
Intervention: Intravascular irradiation of blood (ILIB) combined with myofunctional exercises; active application of ILIB performed twice a week for 8 weeks.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo ILIB combined with myofunctional exercises; application of placebo ILIB and an orofacial myofunctional therapy (MFT) exercise protocol.
Number of subjects: 46
Study: 32117242

Group type: EXPERIMENTAL
Intervention: Optimized immunosuppression
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 59
Study: 32673619

Group type: EXPERIMENTAL
Intervention: therapy with retreat possibility with conspecifics
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: therapy with retreat possibility without conspecifics
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: therapy without retreat possibility
Number of subjects: 20

Group type: COMPARATOR
Intervention: setting without human interaction
Number of subjects: 20
Study: 35695169

Group type: EXPERIMENTAL
Intervention: JNJ-73763989 (200 mg every 4 weeks) + JNJ-56136379 (250 mg daily) + nucleos(t)ide analogue (NA)
Number of subjects: 66

Group type: COMPARATOR
Intervention: JNJ-73763989 (various doses: 35, 100, 200, 300, or 400 mg for non-Japanese; 25, 100, or 200 mg for Japanese)
Number of subjects: 66
Study: 33711782

Group type: EXPERIMENTAL
Intervention: pooled-dose MF/IND
Number of subjects: 10536

Group type: COMPARATOR
Intervention: pooled-dose MF
Number of subjects: 10536

Group type: EXPERIMENTAL
Intervention: pooled-dose MF/IND/GLY
Number of subjects: 10536

Group type: EXPERIMENTAL
Intervention: high-dose MF/IND
Number of subjects: 10536

Group type: COMPARATOR
Intervention: medium-dose MF/IND
Number of subjects: 10536

Group type: EXPERIMENTAL
Intervention: high-dose MF/IND/GLY
Number of subjects: 10536

Group type: COMPARATOR
Intervention: medium-dose MF/IND/GLY
Number of subjects: 10536

Group type: COMPARATOR
Intervention: Fluticasone/Salmeterol (F/S)
Number of subjects: 10536

Group type: COMPARATOR
Intervention: F/S + Tiotropium (TIO)
Number of subjects: 10536
Study: 35303013

Group type: EXPERIMENTAL
Intervention: Inverse group
Number of subjects: 75

Group type: COMPARATOR
Intervention: Balance group
Number of subjects: 75
Study: 32180150

Group type: EXPERIMENTAL
Intervention: Jiannao Yizhi Formula (JYF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Donepezil
Number of subjects: 60
Study: 35982483

Group type: EXPERIMENTAL
Intervention: Olverembatinib (40 mg orally on alternate days for 28-day cycles)
Number of subjects: 165
Study: 32862676

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA) - two doses of maximum 1 g each
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control - two doses of 50 ml 0.9% saline IV
Number of subjects: 81
Study: 616782952

Group type: EXPERIMENTAL
Intervention: Excision surgery combined with autologous corneal limbus stem cell transplantation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Pterygium excision surgery
Number of subjects: 80
Study: 36114949

Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study: 34444838

Group type: EXPERIMENTAL
Intervention: Higher potassium diet (100 mmol K/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Lower potassium diet (40 mmol K/day)
Number of subjects: 29
Study: 35293030

Group type: EXPERIMENTAL
Intervention: apalutamide 240 mg
Number of subjects: 51

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 51
Study: 35090538

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham acupuncture treatment
Number of subjects: 56
Study: 33611342

Group type: EXPERIMENTAL
Intervention: Athletes with ASD
Number of subjects: 435

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Other neurodevelopmental disorders (ADHD, LD, co‐occurring ADHD/LD)
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Post‐concussion Symptom Scale (PCSS)
Number of subjects: 435
Study: 35928723

Group type: EXPERIMENTAL
Intervention: 200 mg LN18178
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 400 mg LN18178
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33518354

Group type: EXPERIMENTAL
Intervention: Diet containing 18% CP and probiotics (0.2 g/kg of diet from Lactobacillus acidophilus and Lactobacillus casei)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Diet containing 14% CP without probiotics
Number of subjects: 180
Study: 32665344

Group type: EXPERIMENTAL
Intervention: Health4Life intervention (six web-based cartoon modules and accompanying activities delivered once per week for 6 weeks, and a smartphone application)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Health4Life intervention
Number of subjects: 72

Group type: COMPARATOR
Intervention: Active control (health education as usual)
Number of subjects: 72
Study: 35025025

Group type: EXPERIMENTAL
Intervention: Cefiderocol 2 g, 3-h infusion, q8h for 7-14 days
Number of subjects: 298

Group type: COMPARATOR
Intervention: Meropenem 2 g, 3-h infusion, q8h for 7-14 days
Number of subjects: 298
Study: 32622648

Group type: EXPERIMENTAL
Intervention: Nurse Practitioners (NPs)
Number of subjects: 814

Group type: EXPERIMENTAL
Intervention: Physicians (MDs)
Number of subjects: 814
Study: 36309119

Group type: EXPERIMENTAL
Intervention: e-health supported intervention focusing on nutrition, exercise, and mental wellbeing, consisting of 4 face-to-face coaching sessions.
Number of subjects: 1075
Study: 33307537

Group type: COMPARATOR
Intervention: Home-based pulmonary rehabilitation
Number of subjects: 73

Group type: COMPARATOR
Intervention: Center-based pulmonary rehabilitation
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Home-based and center-based pulmonary rehabilitation
Number of subjects: 73
Study: 35317821

Group type: EXPERIMENTAL
Intervention: Flexible low-dose antagonist (0.25 mg every other day, adjusted to 0.25 mg daily based on LH levels)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Conventional dose antagonist (0.25 mg per day)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Flexible low-dose antagonist
Number of subjects: 211

Group type: COMPARATOR
Intervention: Conventional dose antagonist
Number of subjects: 211
Study: 33356418

Group type: EXPERIMENTAL
Intervention: Four courses of chemotherapy (including high-dose Ara-C)
Number of subjects: 1017

Group type: COMPARATOR
Intervention: Three courses of chemotherapy
Number of subjects: 1017
Study: 35673256

Group type: EXPERIMENTAL
Intervention: Telehealth-delivered support group intervention (12 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Survey-only control group
Number of subjects: 31
Study: 33739123

Group type: COMPARATOR
Intervention: Local heat (40-42°C applied with a heating pad over the abdomen for 2 hours)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Local heat (38°C applied with a water-perfused heating pad under the torso from 10 pm to 6 am)
Number of subjects: 34
Study: 32350175

Group type: EXPERIMENTAL
Intervention: 750 mg of L-carnitine (LC)
Number of subjects: 11

Group type: COMPARATOR
Intervention: 750 mg of L-carnitine (LC) + 50 g of carbohydrate (CHO)
Number of subjects: 11

Group type: COMPARATOR
Intervention: 30 mg of CoQ10
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 500 mg of L-carnitine (LC)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 500 mg of L-carnitine (LC) + 30 mg of CoQ10
Number of subjects: 11
Study: 35073865

Group type: EXPERIMENTAL
Intervention: CHAPS intervention (nurse-led proactive care management)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: CHAPS intervention
Number of subjects: 140
Study: 33151597

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional non-GLP-1-based therapy
Number of subjects: 35
Study: 35503930

Group type: EXPERIMENTAL
Intervention: Active continuous theta burst stimulation (cTBS) to the primary motor cortex (PMC) and supplementary motor area (SMA)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham stimulation to either the PMC or SMA
Number of subjects: 35
Study: 34718468

Group type: EXPERIMENTAL
Intervention: Bamlanivimab and etesevimab (700/1400 mg)
Number of subjects: 769

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 769
Study: 32924891

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation intervention (five-week intervention integrating group-based activities and home-based activities)
Number of subjects: 0
Study: 32307828

Group type: EXPERIMENTAL
Intervention: Health coaching + web-based program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Web-only group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34645954

Group type: EXPERIMENTAL
Intervention: ECG‐displayed HR assessment
Number of subjects: 51

Group type: COMPARATOR
Intervention: ECG‐blinded HR assessment
Number of subjects: 51
Study: 33219550

Group type: EXPERIMENTAL
Intervention: Cortical perfusion measurement with intraoperative laser speckle imaging and mean arterial blood pressure (MAP) recording
Number of subjects: 24
Study: 35577602

Group type: EXPERIMENTAL
Intervention: 15 U Ultra Rapid Lispro (URLi) administered subcutaneously into the abdomen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 15 U Ultra Rapid Lispro (URLi) administered subcutaneously into the upper arm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 15 U Ultra Rapid Lispro (URLi) administered subcutaneously into the thigh
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) bolus administration of Ultra Rapid Lispro (URLi)
Number of subjects: 0
Study: 33160921

Group type: COMPARATOR
Intervention: RMTMAP approach
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: RMTP approach
Number of subjects: 75
Study: 34515087

Group type: EXPERIMENTAL
Intervention: Mobile teledermoscopy with dermatologist review
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Mobile teledermoscopy services
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Teledermoscopy service (contingent valuation)
Number of subjects: 199
Study: 32797175

Group type: EXPERIMENTAL
Intervention: Buprenorphine prescribers
Number of subjects: 10871

Group type: EXPERIMENTAL
Intervention: Methadone prescribers
Number of subjects: 10871
Study: 33916252

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (general nutritional guidelines)
Number of subjects: 30
Study: 32114812

Group type: EXPERIMENTAL
Intervention: Short intramedullary nail (175 mm)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Standard intramedullary nail (220 mm)
Number of subjects: 229
Study: 35667085

Group type: EXPERIMENTAL
Intervention: 1300 mg TXA orally or 1000 mg TXA IV thrice daily for maximum 30 days
Number of subjects: 337

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 337
Study: 32342559

Group type: EXPERIMENTAL
Intervention: Esencia lens (progressive multifocal and reverse geometry SCL)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional SCLs (control)
Number of subjects: 70
Study: 33284465

Group type: EXPERIMENTAL
Intervention: EGUC system
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: VAS
Number of subjects: 60
Study: 33667677

Group type: EXPERIMENTAL
Intervention: H. pylori seroprevalence
Number of subjects: 16144

Group type: EXPERIMENTAL
Intervention: H. pylori seroprevalence by U.S. born status
Number of subjects: 16144

Group type: EXPERIMENTAL
Intervention: H. pylori seroprevalence by Hispanic/Latino background
Number of subjects: 16144

Group type: EXPERIMENTAL
Intervention: H. pylori seroprevalence associated factors
Number of subjects: 16144
Study: 33454398

Group type: EXPERIMENTAL
Intervention: Kinect based exergaming (EXER)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Combined physical exercise (CPE)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Kinect based exergaming (EXER) and Combined physical exercise (CPE)
Number of subjects: 46
Study: 32533249

Group type: EXPERIMENTAL
Intervention: Active frontotemporal tDCS (10 sessions)
Number of subjects: 17
Study: 32593293

Group type: EXPERIMENTAL
Intervention: BCI-assisted hand motor imagery (MI) training
Number of subjects: 48

Group type: COMPARATOR
Intervention: Hand motor imagery (MI) training not supported by BCI
Number of subjects: 48
Study: 35954982

Group type: EXPERIMENTAL
Intervention: School-based cycling intervention program during Physical Education sessions
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: School-based cycling intervention program
Number of subjects: 122
Study: 33630873

Group type: EXPERIMENTAL
Intervention: WeChat feeding health education platform
Number of subjects: 1804

Group type: COMPARATOR
Intervention: Standard feeding practices
Number of subjects: 1804

Group type: COMPARATOR
Intervention: Standard information sources
Number of subjects: 1804
Study: 32896294

Group type: EXPERIMENTAL
Intervention: Intravenous iron (1000 mg ferric carboxymaltose in 100 mL normal saline, infusion over 15 min)
Number of subjects: 487

Group type: COMPARATOR
Intervention: Placebo (100 mL normal saline, infusion over 15 min)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Intravenous iron
Number of subjects: 487

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 487
Study: 35939921

Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate (PP)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Oral antipsychotics (OAPs)
Number of subjects: 235
Study: 33590363

Group type: EXPERIMENTAL
Intervention: Pulmonary metastasectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32327339

Group type: EXPERIMENTAL
Intervention: Headless compression screws
Number of subjects: 27

Group type: COMPARATOR
Intervention: Plate-and-screws
Number of subjects: 27

Group type: COMPARATOR
Intervention: Pin plates
Number of subjects: 27
Study: 36849056

Group type: EXPERIMENTAL
Intervention: AI‐EARS
Number of subjects: 12
Study: 32770781

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 4079

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4079
Study: 32511682

Group type: EXPERIMENTAL
Intervention: Antibiotic prescribing at visits that met criteria (205 out of 214 visits, 96%)
Number of subjects: 425

Group type: COMPARATOR
Intervention: Antibiotic prescribing at visits that did not meet criteria (193 out of 211 visits, 92%)
Number of subjects: 425
Study: 35040920

Group type: EXPERIMENTAL
Intervention: 5-day antibiotic treatment
Number of subjects: 380

Group type: COMPARATOR
Intervention: 10-day antibiotic treatment
Number of subjects: 380
Study: 34593076

Group type: EXPERIMENTAL
Intervention: Healthy Caregivers-Healthy Children (HC2) intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study: 32675598

Group type: EXPERIMENTAL
Intervention: Epidural group (10-mL solution of 50 mcg of Fentanyl, 0.125% Bupivacaine, and 0.9% saline solution)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Epidural group
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (decompression alone)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 36067389

Group type: EXPERIMENTAL
Intervention: Health problem (e.g., hypertension)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy state (e.g., normal blood pressure)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Addictive disorders
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health problem
Number of subjects: 0
Study: 33094406

Group type: EXPERIMENTAL
Intervention: Potassium oxalate mouth-rinse
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Arginine mouth-rinse
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Herbal extracts mouth-rinse
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control (no mouth-rinse)
Number of subjects: 155
Study: 33185560

Group type: EXPERIMENTAL
Intervention: Overnight pulse oximetry
Number of subjects: 83

Group type: COMPARATOR
Intervention: Once-daily pulse oximetry
Number of subjects: 83

Group type: COMPARATOR
Intervention: Symptom monitoring
Number of subjects: 83
Study: 33941098

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 ?g/kg) for 10 min before surgery infusion (Group D)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Saline infusion for 10 min before surgery (Group S)
Number of subjects: 47
Study: 32284181

Group type: EXPERIMENTAL
Intervention: Probiotics group (1 g of Enterococcus faecium 129 BIO 3B-R, 3 times a day on postoperative days 1-5)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Non-probiotics group
Number of subjects: 33
Study: 35016615

Group type: EXPERIMENTAL
Intervention: Group-based education (n=66)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Routine education in the celiac clinic (n=64)
Number of subjects: 130